ALGOGRAM: YOUR DECISION MAKING GUIDE!

When profiling lead compounds in your discovery programs, you should consider ALGOGram^TM, a unique in vivo screening tool that provides a rapid and cost-effective means to simultaneously explore activity in 10 fully validated pain models / tests across 5 different pain areas:

– Acute & tonic pain
– Inflammatory pain
– Neuropathic pain
– Postoperative pain
– Visceral pain

Information on behavioral toxicity is also provided using the modified Irwin grid.

The simple-to-view plots can provide valuable information regarding the next steps in the development process, whether your R&D programs target pain directly or they simply share features common to established pain mechanisms.

Since ANS Biotech designed this platform, more than 330 test articles have been profiled with ALGOGram^TM.

Within only 3 weeks, ALGOGram^TM can provide a user-friendly pharmacological profile and this “analgesic fingerprint” can facilitate your crucial “GO / NO GO” decisions.

A 2 STEP-PROCESS!

1- ALGOGram™ gives you the analgesic profile of your test articles by detecting efficacy in a given pain area, guiding you in your “GO / NO GO” decisions.

2- The analgesic fingerprint provided by ALGOGram™ can be confirmed and fine-tuned in fully powered studies as a follow-up to this screening step.